» Articles » PMID: 30642949

Reevaluation of the Role of Extracellular Signal-Regulated Kinase 3 in Perinatal Survival and Postnatal Growth Using New Genetically Engineered Mouse Models

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2019 Jan 16
PMID 30642949
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The physiological functions of the atypical mitogen-activated protein kinase extracellular signal-regulated kinase 3 (ERK3) remain poorly characterized. Previous analysis of mice with a targeted insertion of the reporter in the locus ( ) showed that inactivation of ERK3 in mice leads to perinatal lethality associated with intrauterine growth restriction, defective lung maturation, and neuromuscular anomalies. To further explore the role of ERK3 in physiology and disease, we generated novel mouse models expressing a catalytically inactive ( ) or conditional ( ) allele of ERK3. Surprisingly, we found that mice devoid of ERK3 kinase activity or expression survive the perinatal period without any observable lung or neuromuscular phenotype. ERK3 mutant mice reached adulthood, were fertile, and showed no apparent health problem. However, analysis of growth curves revealed that ERK3 kinase activity is necessary for optimal postnatal growth. To gain insight into the genetic basis underlying the discrepancy in phenotypes of different mutant mouse models, we analyzed the regulation of genes flanking the locus by quantitative PCR. We found that the expression of several neighboring genes is deregulated in mice but not in or mutant mice. Our genetic analysis suggests that off-target effects of the targeting construct on local gene expression are responsible for the perinatal lethality phenotype of mutant mice.

Citing Articles

Role of the Atypical MAPK ERK3 in Cancer Growth and Progression.

Elkhadragy L, Myers A, Long W Cancers (Basel). 2024; 16(7).

PMID: 38611058 PMC: 11011113. DOI: 10.3390/cancers16071381.


One-step generation of a conditional allele in mice using a short artificial intron.

Cassidy A, Thomas D, Kuliyev E, Chen H, Pelletier S Heliyon. 2023; 8(12):e12630.

PMID: 36619446 PMC: 9816766. DOI: 10.1016/j.heliyon.2022.e12630.


On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer.

Boudghene-Stambouli F, Soulez M, Ronkina N, Dorrie A, Kotlyarov A, Seternes O Cancers (Basel). 2023; 15(1).

PMID: 36612022 PMC: 9817496. DOI: 10.3390/cancers15010025.


Novel methods for the generation of genetically engineered animal models.

Cassidy A, Onal M, Pelletier S Bone. 2022; 167:116612.

PMID: 36379415 PMC: 9936561. DOI: 10.1016/j.bone.2022.116612.


FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells.

An H, Lee C, Lee G, Choi Y, Jeung D, Chen W Exp Mol Med. 2022; 54(1):35-46.

PMID: 35022544 PMC: 8813941. DOI: 10.1038/s12276-021-00721-9.


References
1.
Deleris P, Rousseau J, Coulombe P, Rodier G, Tanguay P, Meloche S . Activation loop phosphorylation of the atypical MAP kinases ERK3 and ERK4 is required for binding, activation and cytoplasmic relocalization of MK5. J Cell Physiol. 2008; 217(3):778-88. DOI: 10.1002/jcp.21560. View

2.
Schumacher S, Laass K, Kant S, Shi Y, Visel A, Gruber A . Scaffolding by ERK3 regulates MK5 in development. EMBO J. 2004; 23(24):4770-9. PMC: 535084. DOI: 10.1038/sj.emboj.7600467. View

3.
Scacheri P, Crabtree J, Novotny E, Chen A, Edgemon K, Marx S . Bidirectional transcriptional activity of PGK-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice. Genesis. 2001; 30(4):259-63. DOI: 10.1002/gene.1072. View

4.
Kramer A, Green J, Pollard Jr J, Tugendreich S . Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2013; 30(4):523-30. PMC: 3928520. DOI: 10.1093/bioinformatics/btt703. View

5.
Jokela H, Hakkarainen J, Katkanaho L, Pakarinen P, Ruohonen S, Tena-Sempere M . Deleting the mouse Hsd17b1 gene results in a hypomorphic Naglu allele and a phenotype mimicking a lysosomal storage disease. Sci Rep. 2017; 7(1):16406. PMC: 5703720. DOI: 10.1038/s41598-017-16618-5. View